QualityStocksNewsBreaks Archives - Page 733 of 1386

WednesdayFeb 10, 2021 1:51 pm

QualityStocksNewsBreaks – Knightscope Inc. Secures Order from Aerospace Client

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced its receipt of a purchase order from a privately held American aerospace and national security contractor. According to the update, the company is excited to provide an innovative solution for the new client for an undisclosed mission at an undisclosed location. To view the full update, visit https://ibn.fm/S8Vtc About Knightscope Knightscope is an advanced security technology company based in Silicon Valley that builds fully autonomous security robots (“ASRs”) that deter, detect and report. The company’s long-term ambition is to make the United States of…

WednesdayFeb 10, 2021 1:14 pm

QualityStocksNewsBreaks – Uranium Energy Corp. (NYSE American: UEC) CEO Guest on Latest The Bell2Bell Podcast Episode

Uranium Energy (NYSE American: UEC) president and CEO Amir Adnani is the featured guest on the most recent episode of The Bell2Bell Podcast. Hosted by Stuart Smith, The Bell2Bell Podcast, which is an InvestorBrandNework offering, provides insightful updates and inspiring interviews with executives operating in fast-moving industries. During his segment, Adnani provided an overview of UEC’s business model, noting that the company develops uranium projects using the in-situ recovery method, which is both low cost and environmentally friendly. Adnani talked about a few of the company’s projects and operations, including its fully licensed Hobson Processing Facility, one of only a…

WednesdayFeb 10, 2021 12:50 pm

QualityStocksNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Releases Q3 Financial Report

Canopy Rivers (TSX: RIV) (OTC: CNPOF), an investment and acquisition company specializing in cannabis, has shared financial numbers for its most recent period, the three and nine months ended Dec. 31, 2020. The announcement included both unaudited condensed interim consolidated financial statements and management's discussion and analysis ("MD&A"). Numbers in the report indicate that Canopy Rivers’ comprehensive income was $82.2 million, which the company notes was driven by an increase in the value of its investment in TerrAscend. The company also announced a “transformative and accretive” transaction with Canopy Growth; the transaction is scheduled to close by the end of February…

WednesdayFeb 10, 2021 12:37 pm

QualityStocksNewsBreaks – LexaGene Holdings Inc. (TSXV: LXG) (OTCQB: LXXGF) Configures MiQLab(TM) to Detect Variants of COVID-19 Pathogen

LexaGene Holdings (TSXV: LXG) (OTCQB: LXXGF), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, today announced that it has successfully configured a MiQLab(TM) system to detect mutant sequences unique to the United Kingdom (“UK, B.1.1.7”) 1 and South African (“SA, B.1.351”) 2 variants of SARS-CoV-2, the pathogen that causes COVID-19. “Just three weeks ago, we designed assays to detect the UK and SA variants to demonstrate proof-of-principle that these assays could be quickly ported onto the MiQLab,” said Dr. Jack Regan, LexaGene’s CEO and founder. “After just two full work days of having these reagents in-house,…

WednesdayFeb 10, 2021 12:23 pm

QualityStocksNewsBreaks – Sanwire Corp. (SNWR) Announces Creation and Launch of Label Incubator Program

Sanwire (OTC: SNWR), an innovative company with a focus on technologies for the entertainment industry, together with its wholly owned subsidiary Intercept Music Inc., today announced the formation and launch of its Label Incubator Program. The program works as a development suite of marketing and distribution services for artists who have been referred by interested record labels to enhance their online footprint and music exposure while further grooming and developing these artists to advance their path to a recording contract. "Our new Label Incubator Program may be one of the most impactful programs for both Intercept and the artistic clientele…

WednesdayFeb 10, 2021 11:51 am

QualityStocksNewsBreaks – Augusta Gold Inc. (CSE: G) (OTCQB: BFGCD) (FSE: 11B) Announces C$15M Fully Subscribed Private Placement

Augusta Gold (CSE: G) (OTCQB: BFGCD) (FSE: 11B) today announced a fully subscribed non-brokered private placement raising approximately C$15 million. Per the private placement, Augusta will offer 6.7 million units at a price of C$2.25 per unit with each unit comprised of one (1) common share of the company (a "common share") and one half (1/2) of one (1) common share purchase warrant (a "warrant"). Each full warrant entitles the holder to acquire one common share for a period of three years at an exercise price of C$2.80. Augusta Gold intends to utilize the proceeds to advance exploration efforts at…

WednesdayFeb 10, 2021 11:23 am

QualityStocksNewsBreaks – The Movie Studio Inc. (MVES) Releases Moviesode for ‘Cause & Effect’ Utilizing Groundbreaking Format

The Movie Studio (OTC: MVES) today announced the release of Moviesode 1 of the upcoming film “Cause & Effect” (https://vimeo.com/473177048/aaa0f80537 demonstrating the company’s disruptive business model. The company’s Moviesode process fractures linear production of motion picture manufacturing into chapters. When assimilated, the process utilizes the core movie trailer (https://vimeo.com/310897990) and completes the feature film while allowing talent integration, location and product placement to add to the value proposition during the film’s fabrication process. “We are excited to release the first Moviesode for ‘Cause & Effect’ utilizing our groundbreaking ideological format of abbreviated motion picture content manufacturing as we move forward…

WednesdayFeb 10, 2021 11:07 am

QualityStocksNewsBreaks – Harpoon Therapeutics Inc. (NASDAQ: HARP) Closes Underwritten $115M Follow-On Offering

Harpoon Therapeutics (NASDAQ: HARP), a clinical-stage immunotherapy company, announced that it has closed on a previously announced underwritten public offering. The offering consisted of 6,764,704 shares of HARP common stock, including 882,352 additional shares pursuant to the full exercise of the over-allotment option granted to the underwriters. The shares were purchased for $17 a share; the completed IPO resulted in an estimated $15 million in gross proceeds for Harpoon Therapeutics. Harpoon Therapeutics intends to use the proceeds, along with additional available funds, as it continues the clinical development of four products: HPN424 (“HPN424”) is targeting metastatic castration-resistant prostate cancer, HPN536…

WednesdayFeb 10, 2021 10:53 am

QualityStocksNewsBreaks – Friendable Inc.’s (FDBL) Fan Pass Appoints Industry Expert as New VP of Sales, Operations & Business Development

Friendable (OTC: FDBL), a mobile technology and marketing company focused on connecting and engaging users through its proprietary mobile and desktop applications, has named John Haugh as new VP. An industry expert with more than 25 years of experience, Haugh will manage operational growth, brand advertisers, sponsors and new revenue opportunities. Haugh, who himself is a music artist with more than 10,000 touring miles, offers a unique perspective to the new role. His vast background includes experience with media and advertising responsibilities, and he has worked with numerous publishing groups, websites, retail music operations and publishing groups. He has relationships…

WednesdayFeb 10, 2021 10:49 am

QualityStocksNewsBreaks – MAZAKALI CEO Authors Article on Healing Properties of Cannabis

MAZAKALI CEO Sumit Mehta authored a recent News Media online article titled “Cannabis = Indian Medicine, Is One of Humankind’s Most Ancient Healing Herbs.” MAZAKALI is a cannabis-focused fintech marketplace that offers full-scale digital capital raising and investment services across the cannabis complex, including hemp, real estate, supply chain, ancillary and international. In the article, Mehta explains that more than 100 medical applications of cannabis were recorded as far back as 2737 by the father of Chinese medicine, Emperor Shen Nung. Uses for the substance have continued to increase, with scientists in 1992 identifying a previously undiscovered regulation system within…

Site Search

Company Search

Category: QualityStocksNewsBreaks